Human leukocyte antigen (HLA) molecules are a group of proteins that help the immune system identify foreign invaders such as viruses and bacteria and which impact a wide variety of clinical outcomes including infection and cancer. Now Monash Biomedicine Discovery Institute (BDI) researchers have made some important insights into the link between genetic diversity and the intricate changes in peptides bound to HLA molecules that influence these outcomes.